Sallman, D. A., Garcia-Manero, G., Daver, N., Abboud, C. N., Stein, E., Larkin, K., Halpern, A. B., McCurdy, S. R., Malki, M. M. A., Murthy, G. S. G., Silverman, L. R., Larson, R. A., Greenberg, P., Gojo, I., Wróbel, T., Platzbecker, U., Forsyth, C., Vachhani, P., Dong, M., Shao, J., Johnson, L. D., Tan, A., Lee, C., Doshi, P., Vyas, P., Wei, A. H. (2026). Magrolimab Plus Azacitidine Versus Placebo Plus Azacitidine in Patients With Untreated Higher-Risk Myelodysplastic Syndromes: The Phase III ENHANCE Study. Journal of Clinical Oncology. https://doi.org/10.1200/jco-25-00617